Bell Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Bell Bank’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,662	Closed	-$372K	–	135
2015 Q4	$372K	Sell	5,662 -504	-8%	-$31.1K	0.27%	80
2015 Q3	$348K	Sell	6,166 -533	-8%	-$34.6K	0.28%	117
2015 Q2	$396K	Sell	6,699 -802	-11%	-$49.5K	0.29%	116
2015 Q1	$467K	Sell	7,501 -524	-7%	-$30.5K	0.33%	114
2014 Q4	$462K	Sell	8,025 -285	-3%	-$15.9K	0.32%	116
2014 Q3	$447K	Sell	8,310 -533	-6%	-$28.2K	0.32%	120
2014 Q2	$464K	Sell	8,843 -3,294	-27%	-$168K	0.33%	122
2014 Q1	$641K	Sell	12,137 -4,221	-26%	-$195K	0.43%	113
2013 Q4	$656K	Sell	16,358 -24,372	-60%	-$960K	0.34%	131
2013 Q3	$1.54M	Sell	40,730 -2,112	-5%	-$82.4K	0.54%	78
2013 Q2	$1.68M	Buy	+42,842	New	+$1.67M	0.59%	71

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bell Bank's TEVA Position: Q1 2016 in Review

Bell Bank sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 5,662 shares — an estimated $372K sold.

Bell Bank first reported a position in TEVA in Q2 2013 and held it in 11 quarters. The position peaked at $1.68M in Q2 2013. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Bell Bank reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Bell Bank sold 5,662 Teva Pharmaceuticals shares in Q1 2016, an estimated $372K.
Bell Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 11 quarters.
Bell Bank's Teva Pharmaceuticals position peaked at $1.68M in Q2 2013.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Bell Bank's 13F filing for Q1 2016, filed 12 May 2016.